Holding(s) in Company

RNS Number : 6046X
Intl. Biotechnology Trust PLC
18 August 2009
 




TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES


1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):


INTERNATIONAL BIOTECHNOLOGY TRUST PLC


2. Reason for the notification (please place an X inside the appropriate bracket/s):


An acquisition or disposal of voting rights: (X)


An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ()


An event changing the breakdown of voting rights: ()


Other (please specify): ()


3. Full name of person(s) subject to the notification obligation (iii):


AXA S.A, 25 Avenue Matignon, 75008 Paris and its group of companies


4. Full name of shareholder(s) (if different from 3.) (iv):

N/A


5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v):


11 August 2009


6. Date on which issuer notified:


18 August 2009


7. Threshold(s) that is/are crossed or reached:


5%


8. Notified details:


A: Voting rights attached to shares



Class/type of shares if possible using the ISIN CODE

Situation previous to the Triggering transaction (vi)


Number of shares

Number of voting Rights (viii)

Ordinary Shares

GB0004559349

3,319,041

3,319,041



Resulting situation after the triggering transaction (vii)


Class/type of shares if possible using the ISIN CODE

Number of shares 

Number of voting rights (ix)

% of voting rights





Direct (x)

Indirect (xi)

Direct

Indirect

Ordinary Shares

GB0004559349

3,219,041

3,219,041

0

4.97%

0


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction (xii)


Type of financial instrument

Expiration Date (xiii)



Exercise/Conversion Period/ Date (xiv)


Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights



N/A

N/A

N/A

N/A

N/A



C: Financial Instruments with similar economic effect to Qualify Financial Instruments

Resulting situation after the triggering transaction


Type of financial instrument

Exercise price 


Exercise/Conversion Period 

Number of voting rights instrument refers to

% of voting rights





Nominal

Delta

N/A

N/A

N/A

N/A

N/A

N/A



Total (A+B+C)

Number of voting rights

% of voting rights

3,219,041

4.97%


9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv):


Name of the Company/Fund

Number of Shares

% of issued share capital

AXA IM UK

3,203,329

4.94

Sun Life International (IOM) Ltd

15,712

0.03

--------------------

--------------

-------------

Total

3,219,041

4.97


Proxy Voting:


10. Name of the proxy holder:


N/A


11. Number of voting rights proxy holder will cease to hold:


N/A


12. Date on which proxy holder will cease to hold voting rights:


N/A


13. Additional information:


N/A


14. Contact name:


RACHAEL NELSON, FOR AND ON BEHALF OF BNP PARIBAS SECRETARIAL SERVICES LIMITED


15. Contact telephone number:


020 7410 3132

    

Date: 18 AUGUST 2009


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUWVWRKKRWARR
Investor Meets Company
UK 100